PUBLISHER: KBV Research | PRODUCT CODE: 1462062
PUBLISHER: KBV Research | PRODUCT CODE: 1462062
North America HIV Injection Market Size, Share & Trends Analysis Report By Distribution Channel (Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others), By Country and Growth Forecast, 2023 - 2030
The North America HIV Injection Market would witness market growth of 16.9% CAGR during the forecast period (2023-2030).
The US market dominated the North America HIV Injection Market by Country in 2022 and would continue to be a dominant market till 2030; thereby, achieving a market value of $905.8 Million by 2029. The Canada market is experiencing a CAGR of 19.6% during (2023 - 2030). Additionally, The Mexico market would exhibit a CAGR of 18.5% during (2023 - 2030).
HIV (Human Immunodeficiency Virus) is a pathogen that targets the immune system's CD4 cells (T cells), which are crucial for defending against infections. HIV reduces the number of CD4 cells in the body, increasing the risk of infection-related cancers and infections if left untreated. A progressive depletion of these cells by HIV may render the body incapable of combating infections and diseases.
HIV is transmitted through contact with specific bodily fluids from an infected individual, including blood, sperm, vaginal fluids, rectal fluids, and breast milk. Sexual contact without protection, sharing needles or syringes with an infected person, and transmission from mother to child during childbirth or breastfeeding are the most prevalent modes of HIV transmission.
A significant public health concern is the increasing prevalence of HIV in North America, especially in certain populations and geographic regions. An increasing prevalence of HIV is also being observed in Canada. The Government of Canada reports that with 1,472 new cases, representing an 11.3% increase, the national rate of new HIV diagnoses for 2021 stood at 3.8 per 100,000 population. Hence, all of these factors will aid in the market's growth.
Based on Distribution Channel, the market is segmented into Hospital Pharmacy, Drugs Stores & Retail Pharmacies, and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
List of Key Companies Profiled
- GlaxoSmithKline PLC (GSK)
- Gilead Sciences, Inc.
- ImmunityBio, Inc.
- F. Hoffmann-La Roche Ltd.
- Theratechnologies Inc.
- Viriom, Inc.
- AbbVie, Inc.
- Brii Biosciences Limited
- Shionogi & Co., Ltd.
- Boehringer Ingelheim International GmbH
North America HIV Injection Market Report Segmentation
By Distribution Channel
- Hospital Pharmacy
- Drugs Stores & Retail Pharmacies
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Table of Contents
Chapter 1.Market Scope & Methodology
- 1.1Market Definition
- 1.2Objectives
- 1.3Market Scope
- 1.4Segmentation
- 1.4.1North America HIV Injection Market, by Distribution Channel
- 1.4.2North America HIV Injection Market, by Country
- 1.5Methodology for the research
Chapter 2.Market at a Glance
- 2.1Key Highlights
Chapter 3.Market Overview
- 3.1Introduction
- 3.1.1Overview
- 3.1.1.1Market Composition and Scenario
- 3.1.1Overview
- 3.2Key Factors Impacting the Market
- 3.2.1Market Drivers
- 3.2.2Market Opportunities
- 3.2.3Market Restraints
- 3.2.4Market Challenges
- 3.3Porter's Five Forces Analysis
Chapter 4.North America HIV Injection Market by Distribution Channel
- 4.1North America Hospital Pharmacy Market by Country
- 4.2North America Drugs Stores & Retail Pharmacies Market by Country
- 4.3North America Others Market by Country
Chapter 5.North America HIV Injection Market by Country
- 5.1US HIV Injection Market
- 5.1.1US HIV Injection Market by Distribution Channel
- 5.2Canada HIV Injection Market
- 5.2.1Canada HIV Injection Market by Distribution Channel
- 5.3Mexico HIV Injection Market
- 5.3.1Mexico HIV Injection Market by Distribution Channel
- 5.4Rest of North America HIV Injection Market
- 5.4.1Rest of North America HIV Injection Market by Distribution Channel
Chapter 6.Company Profiles
- 6.1GlaxoSmithKline PLC (GSK)
- 6.1.1Company Overview
- 6.1.2Financial Analysis
- 6.1.3Regional Analysis
- 6.1.4Research & Development Expense
- 6.1.5SWOT Analysis
- 6.1Gilead Sciences, Inc.
- 6.1.1Company overview
- 6.1.2Financial Analysis
- 6.1.3Research & Development Expenses
- 6.1.4SWOT Analysis
- 6.2ImmunityBio, Inc.
- 6.2.1Company Overview
- 6.2.2Financial Analysis
- 6.2.3Regional Analysis
- 6.2.4Research & Development Expenses
- 6.2.5SWOT Analysis
- 6.3F. Hoffmann-La Roche Ltd.
- 6.3.1Company Overview
- 6.3.2Financial Analysis
- 6.3.3Segmental and Regional Analysis
- 6.3.4Research & Development Expense
- 6.3.5SWOT Analysis
- 6.4Theratechnologies Inc.
- 6.4.1Company Overview
- 6.4.2Financial Analysis
- 6.4.3Research & Development Expenses
- 6.4.4SWOT Analysis
- 6.5Viriom, Inc.
- 6.5.1Company Overview
- 6.5.2SWOT Analysis
- 6.6AbbVie, Inc.
- 6.6.1Company Overview
- 6.6.2Financial Analysis
- 6.6.3Regional Analysis
- 6.6.4Research & Development Expense
- 6.6.5SWOT Analysis
- 6.7Brii Biosciences Limited
- 6.7.1Company Overview
- 6.7.2Financial Analysis
- 6.7.3Research & Development Expenses
- 6.7.4SWOT Analysis
- 6.8Shionogi & Co., Ltd.
- 6.8.1Company Overview
- 6.8.2Financial Analysis
- 6.8.3Research & Development Expenses
- 6.8.4SWOT Analysis
- 6.9Boehringer Ingelheim International GmbH
- 6.9.1Company Overview
- 6.9.2Financial Analysis
- 6.9.3Regional & Segmental Analysis
- 6.9.4Research & Development Expenses
- 6.9.5SWOT Analysis
LIST OF TABLES
- TABLE 1North America HIV Injection Market, 2019 - 2022, USD Million
- TABLE 2North America HIV Injection Market, 2023 - 2030, USD Million
- TABLE 3North America HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 4North America HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 5North America Hospital Pharmacy Market by Country, 2019 - 2022, USD Million
- TABLE 6North America Hospital Pharmacy Market by Country, 2023 - 2030, USD Million
- TABLE 7North America Drugs Stores & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
- TABLE 8North America Drugs Stores & Retail Pharmacies Market by Country, 2023 - 2030, USD Million
- TABLE 9North America Others Market by Country, 2019 - 2022, USD Million
- TABLE 10North America Others Market by Country, 2023 - 2030, USD Million
- TABLE 11North America HIV Injection Market by Country, 2019 - 2022, USD Million
- TABLE 12North America HIV Injection Market by Country, 2023 - 2030, USD Million
- TABLE 13US HIV Injection Market, 2019 - 2022, USD Million
- TABLE 14US HIV Injection Market, 2023 - 2030, USD Million
- TABLE 15US HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 16US HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 17Canada HIV Injection Market, 2019 - 2022, USD Million
- TABLE 18Canada HIV Injection Market, 2023 - 2030, USD Million
- TABLE 19Canada HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 20Canada HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 21Mexico HIV Injection Market, 2019 - 2022, USD Million
- TABLE 22Mexico HIV Injection Market, 2023 - 2030, USD Million
- TABLE 23Mexico HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 24Mexico HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 25Rest of North America HIV Injection Market, 2019 - 2022, USD Million
- TABLE 26Rest of North America HIV Injection Market, 2023 - 2030, USD Million
- TABLE 27Rest of North America HIV Injection Market by Distribution Channel, 2019 - 2022, USD Million
- TABLE 28Rest of North America HIV Injection Market by Distribution Channel, 2023 - 2030, USD Million
- TABLE 29Key Information - GlaxoSmithKline PLC
- TABLE 30Key Information - Gilead Sciences, Inc.
- TABLE 31Key Information - ImmunityBio, Inc.
- TABLE 32Key Information - F. Hoffmann-La Roche Ltd.
- TABLE 33Key Information - Theratechnologies Inc.
- TABLE 34Key Information - Viriom, Inc.
- TABLE 35Key information - AbbVie, Inc.
- TABLE 36Key Information - Brii Biosciences Limited
- TABLE 37Key Information - Shionogi & Co., Ltd.
- TABLE 38Key Information - Boehringer Ingelheim International GmbH
